NIH SBIR Phase I
Funds early stage United States biomedical teams through NIH seed support for feasibility work on prototype ready ideas.
NIH SBIR Phase I awards are non-dilutive grants that support feasibility studies and early-stage technical merit assessments for biomedical and health-related innovations developed by US small businesses. NIH sets aside more than $1.4 billion annually from its extramural R&D budget specifically for its Small Business Programs (SBIR and STTR combined), making it the largest source of non-dilutive e…
Researcher-initiated biomedical and health-related R&D feasibility studies across all 24 participating NIH Institutes and Centers, with topic priorities set by each IC.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline